Management and clinical outcomes in uterine malignant mixed Müllerian tumor: Lessons from a single-institution series.

MLA

Dasanu, Constantin A., et al. “Management and Clinical Outcomes in Uterine Malignant Mixed Müllerian Tumor: Lessons from a Single-Institution Series.” Journal of Oncology Pharmacy Practice, vol. 26, no. 3, Apr. 2020, pp. 688–91. EBSCOhost, https://doi.org/10.1177/1078155219869441.

APA

Dasanu, C. A., Iskandar, A. S., Hwang, A., Kerr, W. T., Farrell, S., Grover, M., Ocampo, M. M., Lerner, J., & Plaxe, S. C. (2020). Management and clinical outcomes in uterine malignant mixed Müllerian tumor: Lessons from a single-institution series. Journal of Oncology Pharmacy Practice, 26(3), 688–691. https://doi.org/10.1177/1078155219869441

Chicago

Dasanu, Constantin A, Andrew S Iskandar, Andrew Hwang, Wesley T Kerr, Stephanie Farrell, Mayumi Grover, Miguel Michel Ocampo, Jaren Lerner, and Steven C Plaxe. 2020. “Management and Clinical Outcomes in Uterine Malignant Mixed Müllerian Tumor: Lessons from a Single-Institution Series.” Journal of Oncology Pharmacy Practice 26 (3): 688–91. doi:10.1177/1078155219869441.